These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22642002)
1. [You have to take the prostate cancer seriously]. Stief CG MMW Fortschr Med; 2012 Jan; 154(1):42. PubMed ID: 22642002 [No Abstract] [Full Text] [Related]
3. [Screening and prevention of prostate cancer]. Roosen A MMW Fortschr Med; 2010 May; 152(19):37-9. PubMed ID: 20557000 [No Abstract] [Full Text] [Related]
4. [Prostate cancer screening: no proof of the benefit]. Laplanche A; Hill C Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979 [No Abstract] [Full Text] [Related]
6. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe. Brenner H; Heywang-Köbrunner S; Becker N J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365 [No Abstract] [Full Text] [Related]
8. Risk of dying from early prostate cancer is low regardless of treatment, study finds. White C BMJ; 2016 Sep; 354():i4984. PubMed ID: 27633860 [No Abstract] [Full Text] [Related]
9. [PSA 2010--the beginning of a new era in early detection of prostate cancer]. Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115 [No Abstract] [Full Text] [Related]
10. Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. Braillon A; Dubois G J Natl Cancer Inst; 2012 May; 104(10):793; author reply 793-4. PubMed ID: 22491229 [No Abstract] [Full Text] [Related]
11. Further evidence that prostate-specific antigen screening reduces prostate cancer mortality. Stampfer MJ; Jahn JL; Gann PH J Natl Cancer Inst; 2014 Mar; 106(3):dju026. PubMed ID: 24610908 [No Abstract] [Full Text] [Related]
12. Reconsidering Prostate Cancer Screening. Schmidt C J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781 [No Abstract] [Full Text] [Related]
13. Prostate specific antigen testing: age-related interpretation in early prostate cancer detection. McKenzie PR; Delahunt B; Kench JG; Ross B; Lam Q; deVoss K; Tran HA; Sikaris KA Pathology; 2013 Jun; 45(4):343-5. PubMed ID: 23619589 [No Abstract] [Full Text] [Related]
19. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? Hoeltl W; Müller MM; Lunglmayr G J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895 [No Abstract] [Full Text] [Related]
20. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Taneja SS J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657 [No Abstract] [Full Text] [Related] [Next] [New Search]